• 1. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

Professional Introduction to (Cyclopropylmethyl)(4-methylpentan-2-yl)amine and Its CAS No. 1019507-35-7

(Cyclopropylmethyl)(4-methylpentan-2-yl)amine, identified by its CAS number 1019507-35-7, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This amine derivative exhibits a unique structural configuration that positions it as a versatile intermediate in the development of novel therapeutic agents. The compound's molecular framework, featuring a cyclopropylmethyl group and a 4-methylpentan-2-yl chain, contributes to its distinct chemical properties and reactivity, making it a valuable candidate for further exploration in medicinal chemistry.

The cyclopropylmethyl moiety, characterized by its three-membered ring structure, introduces steric hindrance and electronic effects that can influence the compound's interactions with biological targets. This structural feature is particularly relevant in the design of enzyme inhibitors and receptor modulators, where precise spatial orientation and binding affinity are critical. In contrast, the 4-methylpentan-2-yl group provides a longer alkyl chain that can enhance solubility and metabolic stability, factors that are often crucial for drug-like properties.

Recent advancements in computational chemistry have enabled more accurate predictions of the pharmacokinetic profiles of such compounds. Studies utilizing molecular modeling techniques have shown that (Cyclopropylmethyl)(4-methylpentan-2-yl)amine exhibits favorable binding interactions with several protein targets, suggesting its potential as a lead compound in drug discovery. For instance, research has indicated that this amine derivative may interact with enzymes involved in metabolic pathways relevant to inflammation and neurodegeneration. Such findings underscore the importance of exploring structurally diverse compounds like this one for addressing complex diseases.

In the realm of synthetic organic chemistry, the preparation of CAS no. 1019507-35-7 has been optimized through various methodologies, including multi-step functional group transformations and transition metal-catalyzed reactions. The synthesis typically involves the coupling of cyclopropylmethyl halides with appropriately substituted amine precursors, followed by purification steps to isolate the desired product. These synthetic routes highlight the compound's accessibility and feasibility for large-scale production, which is essential for preclinical and clinical studies.

The pharmacological evaluation of (Cyclopropylmethyl)(4-methylpentan-2-yl)amine has been conducted in several preclinical models, revealing promising activities in vitro and in vivo. Notably, preliminary studies have demonstrated its ability to modulate signaling pathways associated with cell proliferation and apoptosis. These effects are particularly intriguing given the growing interest in small molecule modulators as therapeutic agents for cancer and other chronic diseases. Additionally, the compound's lack of significant toxicity in animal models suggests a favorable safety profile, which would be advantageous for further development.

The integration of machine learning algorithms into drug discovery pipelines has further accelerated the exploration of compounds like this one. By leveraging large datasets of chemical structures and biological activities, computational models can predict potential therapeutic utilities with increasing precision. This approach has already been instrumental in identifying novel analogs of CAS no. 1019507-35-7 with enhanced efficacy or improved pharmacokinetic properties. Such innovations highlight the synergy between experimental chemistry and computational science in advancing pharmaceutical research.

The industrial relevance of (Cyclopropylmethyl)(4-methylpentan-2-yl)amine extends beyond academic research, as it represents a class of compounds that could be commercialized for various applications. Pharmaceutical companies are increasingly seeking innovative intermediates to streamline their drug development processes, and this amine derivative offers a compelling option due to its structural complexity and functional diversity. Furthermore, its compatibility with green chemistry principles—such as solvent efficiency and waste minimization—aligns with industry trends toward sustainable manufacturing practices.

Future directions in the study of this compound may include exploring its role in combinatorial therapy regimens, where it could be paired with other agents to achieve synergistic effects. Additionally, investigating its potential as a prodrug—a precursor that is metabolically converted into an active therapeutic—could open new avenues for treatment modalities. The versatility of CAS no. 1019507-35-7 ensures that it will remain a subject of intense interest among researchers aiming to develop next-generation pharmaceuticals.

In conclusion, (Cyclopropylmethyl)(4-methylpentan-2-yl)amine (CAS no. 1019507-35-7) is a structurally unique amine derivative with significant promise in pharmaceutical applications. Its distinctive molecular features, combined with recent advancements in synthetic and computational chemistry, position it as a valuable asset in drug discovery efforts. As research continues to uncover new therapeutic possibilities for this compound, it will undoubtedly play an important role in shaping the future of medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)